Drug recall

Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs…

FDA recall event 97573 · Class III · JB Chemicals and Pharmaceuticals Ltd

Key facts

Event ID 97573
Recall numbers D-0032-2026, D-0033-2026
Recalling firm JB Chemicals and Pharmaceuticals Ltd
Product type Drugs
Products Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed…, Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed…
Classification Class III
Status Ongoing
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Tablet/Capsules Imprinted with Wrong ID
Initiation date Sep 12, 2025
Report date Oct 29, 2025
City Mumbai
Country India
FEI number 3006377057

At a glance

  • 1–9 Products in this recall
  • None FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls